Found: 6
Select item for more details and to access through your institution.
Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 9, p. 1150, doi. 10.1002/jcph.2448
- By:
- Publication type:
- Article
Correction to: Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus<sup>®</sup>) and Lantus<sup>®</sup> in healthy subjects: a double-blind, randomized clamp study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus<sup>®</sup>) and Lantus<sup>®</sup> in healthy subjects: a double-blind, randomized clamp study.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 461, doi. 10.1007/s00592-018-1113-3
- By:
- Publication type:
- Article
A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 8, p. 915, doi. 10.1002/cpdd.1415
- By:
- Publication type:
- Article
Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 7, p. 755, doi. 10.1002/jcph.2229
- By:
- Publication type:
- Article
Quantitation of Cabozantinib in Human Plasma by LC–MS/MS.
- Published in:
- Journal of Chromatographic Science, 2022, v. 60, n. 3, p. 274, doi. 10.1093/chromsci/bmab090
- By:
- Publication type:
- Article